Emergency room overutilization is a significant issue in oncology care and may increase healthcare expenditures while lowering the quality of patient care.
Emergency room (ER) overutilization is a significant issue in oncology care and may increase healthcare expenditures while lowering the quality of patient care. In reviewing the number of ER visits between January and May of 2015, researchers noticed that only 48% of visits occurred during office hours.
The goal of the study, being published in the Journal of Clinical Oncology, was to reduce ER visits by 30%. The results are also being presented at the 2016 American Society of Clinical Oncology Quality Care Symposium.
“By implementing this new system, our goal was to reduce unnecessary patient discomfort, interruptions in treatment, and financial burden,” lead study author Brian Hunis, MD, said in a statement.
The researchers introduced a quality improvement initiative in order to address the overutilization of the ER for cancer treatment side effects, calling it the plan-do-study act (PDSA). PDSA #1 focused on a phone triage system, where center staff was trained to evaluate the severity of patient systems and decide when an ER referral was appropriate, with a triage nurse available for consultation.
PDSA #2 incorporated the education of patients on chemotherapy side effects and how to handle them when office hours were closed. Patients were also provided “chemotherapy passports,” depicting the oncologist’s name, contract information, chemotherapy regimen, date of last session, and potential side effects that might warrant hospital admission. They were encouraged to call the patient access center with any questions.
Other materials were later developed: a phone triage form describing the patient’s complaint and the patient access center response, and a log describing call-ins, their data, and which of the staff members was responsible.
This initiative was implemented at Memorial Healthcare System, which includes 5 public hospitals within southern Florida. As a result of this initiative, the team saw a reduction in ER services by 60%, 4 months after implementation.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More